We are live on ! Find out more
DMTX

Dimension Therapeutics, Inc
DMTX

Delisted

DMTX was delisted on the 6th of November, 2017.

Back to rankings

34 hedge funds and large institutions have $109M invested in Dimension Therapeutics, Inc in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 3 increasing their positions, 11 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

326% more capital invested

Capital invested by funds: $25.7M → $109M (+$83.7M)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 11

3% less funds holding

Funds holding: 35 → 34 (-1)

73% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 11

Holders
34
Holders Change
-1
Holders Change %
-2.86%
% of All Funds
0.85%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
11
Increased
3
Reduced
11
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
HIM
HGC Investment Management
Ontario, Canada
+$794K
2
PAMP
Polar Asset Management Partners
Ontario, Canada
+$493K
3
KPF
K2 Principal Fund
Ontario, Canada
+$415K
4
KAM
Kassirer Asset Management
Ontario, Canada
+$412K
5
Tudor Investment Corp
Tudor Investment Corp
Connecticut
+$261K

Top Sellers

1
WMSA
Weiss Multi-Strategy Advisers
New York
-$675K
2
Millennium Management
Millennium Management
New York
-$353K
3
RSCM
Rock Springs Capital Management
Maryland
-$120K
4
Goldman Sachs
Goldman Sachs
New York
-$117K
5
Wells Fargo
Wells Fargo
California
-$111K
Name Holding Trade Value Shares
Change 		Change in
Stake
SIM
26
Spark Investment Management
New York
$118K +$51.2K +19,729 New
Morgan Stanley
27
Morgan Stanley
New York
$115K -$207 -80 -0.4%
State Street
28
State Street
Massachusetts
$97K – – –
Wells Fargo
29
Wells Fargo
California
$76K -$111K -42,633 -77%
Bank of America
30
Bank of America
North Carolina
$63K -$11.5K -4,452 -30%
Deutsche Bank
31
Deutsche Bank
Germany
$19K -$156 -60 -2%
MAM
32
Meeder Asset Management
Ohio
$4K -$358 -138 -19%
UBS Group
33
UBS Group
Switzerland
$1K -$586 -226 -67%
Goldman Sachs
34
Goldman Sachs
New York
– -$117K -80,471 Closed
LP
35
LMR Partners
United Kingdom
– -$80K -55,027 Closed
PP
36
Paloma Partners
Connecticut
– -$46K -31,800 Closed
ARTA
37
A.R.T. Advisors
New York
– -$45K -31,245 Closed
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
– -$33K -22,767 Closed
JP Morgan Chase
39
JP Morgan Chase
New York
– -$16K -10,713 Closed
TRCT
40
Tower Research Capital (TRC)
New York
– -$14K -10,035 Closed
Barclays
41
Barclays
United Kingdom
– -$8K -5,809 Closed
Manulife (Manufacturers Life Insurance)
42
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$1K -729 Closed
PAM
43
Panagora Asset Management
Massachusetts
– -$1K -448 Closed
Royal Bank of Canada
44
Royal Bank of Canada
Ontario, Canada
– +$23 +9 New
1
2

DMTX Hedge Fund Activity: Q3 2017 in Review

34 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q3 2017, worth a combined $109M — up 326% from $25.7M a quarter earlier.

Fund positioning in DMTX was balanced in Q3 2017: 11 funds opened new positions, 11 closed out, 3 added to existing stakes and 11 trimmed.

The largest buyer was HGC Investment Management, opening a new position worth an estimated $794K. The largest seller was Weiss Multi-Strategy Advisers, cutting an estimated $675K.

  • 34 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q3 2017, down from 35 in Q2 2017.
  • Funds reported $109M of Dimension Therapeutics, Inc stock for Q3 2017, up 326% quarter-over-quarter.
  • 11 funds opened new Dimension Therapeutics, Inc positions in Q3 2017 and 11 closed out, a net change of 0 holders.
  • The largest Dimension Therapeutics, Inc buyer in Q3 2017 was HGC Investment Management, an estimated $794K added.
  • The largest Dimension Therapeutics, Inc seller in Q3 2017 was Weiss Multi-Strategy Advisers, an estimated $675K sold.

Based on aggregated 13F filings for Q3 2017.